The FDA is reminding the public about the safe use of hyperbaric oxygen therapy devices and is providing recommendations to help reduce potential risks.
Similar Posts
FDA Approves First Over-the-Counter Naloxone Nasal Spray
The U.S. Food and Drug Administration approved the first naloxone nasal spray product available without a prescription.Ashfiat Alharamain Energy Support may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Ashfiat Alharamain Energy Support, a product promoted and sold for male sexual enhancement on various websites, including Amazon.com (Akkarco, LLC storefront), and possibly in some retail stores.Accupack Midwest, Inc. – 680228 – 08/15/2024
CGMP/Finished Pharmaceuticals/AdulteratedSanofi S.p.A. – 05/22/2023
Sanofi S.p.A. – 05/22/2023. Country: Italy. Record Type: 483Spring & Mulberry Expands Voluntary Recall of Select Chocolate Bars Due to Possible Salmonella Contamination
Raleigh, North Carolina (January 14, 2026) — Spring & Mulberry is updating their press release previously issued on January 12, 2026, to expand their voluntary recall beyond Mint Leaf to include additional flavors (see table below), due to possible contamination with Salmonella.CDER Leadership Bios
CDER Leadership Bios